A descriptive analysis of sarcopenia markers in young adults with down syndrome
Experimental Gerontology · 2025
DOI: 10.1016/j.exger.2024.112655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Gerontology, 2025. Verfasst von Brett S Nickerson und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH, USA. Electronic address: brett.nickerson@osumc.edu. Hauptthemen laut MEDLINE: Sarcopenia, Down Syndrome, Hand Strength, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, National Institutes of Health, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
BACKGROUND: Most body composition research in individuals with Down Syndrome (DS) has focused on overweight and obesity. Although limited research has shown muscle mass indexes and physical performance levels of adults with DS are similar to or lower than older adults with sarcopenia, there is still a large gap in the literature regarding sarcopenia. OBJECTIVE: This brief report provides a comprehensive descriptive analysis of sarcopenia and obesity markers in individuals with DS. METHODS: Fourteen young adults (age = 26 ± 9 yrs.) with DS (males: n = 6; females: n = 8) had appendicular skeletal muscle mass (ASM) measured with bioimpedance analysis and handgrip strength (HGS) measured with a hand dynamometer (dominant hand). Sarcopenia was computed using the European Working Group on Sarcopenia in Older People revised definition (EWGSOP2). RESULTS: The BMI for the entire group was 24.41 ± 4.01 kg/m2, ranging from 16.21 to 31.31 kg/m2, with one participant classified as obese. ASM ranged from 11.33 to 24.41 kg (17.49 ± 4.71 kg), and 64 % of participants fell below the EWGSOP2 criteria for muscle mass. HGS ranged from 8 to 31 kg (20 ± 7 kg), and 57 % of participants fell below the EWGSOP2 criteria for muscular strength. Lastly, 5 of 14 participants (approximately 36 %) had sarcopenia according to the EWGSOP2 definition. CONCLUSION: An alarming number of young adults with DS had sarcopenia, and low HGS and ASM when using the EWGSOP2 definition. Health professionals are encouraged to screen for sarcopenia in young adulthood rather than deferring it to a later stage in life for individuals with DS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH, USA. Electronic address: brett.nickerson@osumc.edu.
- Department of Kinesiology, The University of Alabama, Tuscaloosa, AL, USA.
- Departement of Kinesiology, Auburn University Montgomery, Montgomery, AL, USA.
- School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH, USA.
Förderung
- NICHD NIH HHS
- National Institutes of Health
- National Institute of Child Health and Human Development
Zitieren
APA
Nickerson, B. S., Esco, M. R., Schaefer, G., Aguiar, E. J., & Czerwinski, S. A. (2025). A descriptive analysis of sarcopenia markers in young adults with down syndrome. Experimental Gerontology. https://doi.org/10.1016/j.exger.2024.112655
Vancouver
Nickerson BS, Esco MR, Schaefer G, Aguiar EJ, Czerwinski SA. A descriptive analysis of sarcopenia markers in young adults with down syndrome. Experimental Gerontology. 2025. doi:10.1016/j.exger.2024.112655
BibTeX
@article{Nickerson2025,
author = {Nickerson, Brett S and Esco, Michael R and Schaefer, George and Aguiar, Elroy J and Czerwinski, Stefan A},
title = {A descriptive analysis of sarcopenia markers in young adults with down syndrome},
journal = {Experimental Gerontology},
year = {2025},
doi = {10.1016/j.exger.2024.112655}
}
EUVIMED